pharma · Rheumatoid Arthritis · Multiple Myeloma
Centocor
Centocor B.V.
Centocor is a pharma organization headquartered in EU. Primary therapeutic focus areas include Rheumatoid Arthritis, Multiple Myeloma. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent record(s)
Malvern, USA HQ
1979 Founded
568 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Malvern, USA
- Founded
- 1979
- Employees
- 568
- Programs
- 2
- Drugs
- 4
- Patents
- 1
Placebo, Velcade and dexamethasone
Phase 3 · small molecule · Multiple Myeloma
Placebo, Velcade and dexamethasone for Multiple Myeloma is a Phase 3 program (small_molecule) at Centocor B.V. with 1 ClinicalTrials.gov record(s).
Internal code CR017743
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Centocor B.V.
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Multiple Myeloma
- Status
- terminated
- Trials
- 1